𝔖 Bobbio Scriptorium
✦   LIBER   ✦

CD95 ligand expression as a criterion of malignant transformation in breast cancer

✍ Scribed by Markus Müschen; Matthias W. Beckmann

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
54 KB
Volume
191
Category
Article
ISSN
0022-3417

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CD95 ligand expression in dedifferentiat
CD95 ligand expression in dedifferentiated breast cancer
✍ M�schen, Markus; Moers, Cordula; Warskulat, Ulrich; Niederacher, Dieter; Betz, B 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 412 KB 👁 2 views

CD95 ligand expression has been observed in various malignancies. Studying the CD95 ligand (CD95L) and receptor (CD95) system in eight non-malignant mammary tissues and 40 breast cancer tissues, mRNA and protein expression was determined by quantitative reverse transcriptase-polymerase chain reactio

Algorithms for quantitation of protein e
Algorithms for quantitation of protein expression variation in normal versus tumor tissue as a prognostic factor in cancer: Met oncogene expression, and breast cancer as a model
✍ Rom T. Altstock; Gideon Y. Stein; James H. Resau; Ilan Tsarfaty 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 482 KB 👁 1 views

## Background: Immunohistochemistry and immunofluorescence (if) assays frequently rely on subjective observer evaluation for grading. the aim of our study was to develop an objective quantitative index based on confocal laser scanning microscopy (clsm) and image analysis of an if assay to determine